Pleiotropic, Unique and Shared Responses Elicited by IL-6 Family Cytokines in Human Vascular Endothelial Cells

Abstract

Vascular endothelial cells express glycoprotein 130 (gp130), which is utilized as a signaling receptor by cytokines in the interleukin-6 (IL-6) family. Several IL-6 family cytokines can be found in the circulatory system during physiological or pathological conditions, and may influence endothelial function and response. This study evaluated and compared the cellular and molecular responses induced by IL-6 family cytokines in human endothelial cells. A proteomic analysis showed that IL-6 family cytokines induce the release of a range of proteins from endothelial cells, such as C-C motif chemokine ligand 23, hepatocyte growth factor, and IL-6. Pathway analysis indicated that gp130-signaling in endothelial cells regulates several functions related to angiogenesis and immune cell recruitment. The present investigation also disclosed differences and similarities between different IL-6 family cytokines in their ability to induce protein release and regulate gene expression and intracellular signaling, in regards to which oncostatin M showed the most pronounced effect. Further, this study showed that soluble gp130 preferentially blocks trans-signaling-induced responses, but does not affect responses induced by classic signaling. In conclusion, IL-6 family cytokines induce both specific and overlapping molecular responses in endothelial cells, and regulate genes and proteins involved in angiogenesis and immune cell recruitment.

The Effects of Silencing PTX3 on the Proteome of Human Endothelial Cells

“…IL-1β can induce its own gene expression, providing a positive feedback amplification loop for enhancing its levels at the site of inflammation. In addition, IL-1β boosts the production of IL-6 that, in turn, drives the expression of atherothrombosis mediators [ 48 ]. Notably, IL-1β also stimulates the synthesis of pro-inflammatory prostaglandins through the production of the inducible COX-2 enzyme [ 28 ].…”

Advances in Endothelial Cell Biology: From Knowledge to Control

“…The Special Issue reflects the need to take into account the heterogeneity of ECs among organs and tissues and to develop EC-targeted therapeutic strategies in experimental models and for clinical applications. Illustrating this point, this issue displays studies using a variety of ECs to explore dedicated functions including human umbilical vein ECs [ 1 ], pulmonary [ 2 ], renal glomerular [ 3 ], cerebral [ 4 ] and tumor ECs [ 5 ] but also adherent versus non adherent ECs [ 6 ] and ECs isolated from adults versus young children [ 3 ]. A better understanding of microvascular ECs’ heterogeneity will provide a roadmap for developing novel therapeutics to target the endothelium.…”

“…The presence of hemoglobin during treatment with S1 protein as a mean to counterbalance hypoxic environment failed to inhibit S1 signaling in ECs. As a link between infection and inflammation, Lindkvist et al investigate how the IL-6 family cytokines, which can be found in the circulatory system during physiological or pathological conditions, may use selective receptors and signaling pathways to influence endothelial function and response [ 1 ]. Investigating the pathophysiology of hypertension in hypertensive mice after the administration of angiotensin II, Kij et al show that inhibiting thrombin prevents the development of endothelial dysfunction, increased systemic nitric oxide (NO) bioavailability, and limited endothelial inflammation but did not reduce elevated blood pressure and aortic thickening induced by angiotensin II [ 12 ].…”

Endothelial glycocalyx in hepatopulmonary syndrome: An indispensable player mediating vascular changes

“…During this process, the EMCN within the eGCX layer facilitates VEGFR2 internalization and downstream signaling as previously mentioned. Some systemically elevated factors may promote VEGFR2 internalization as well during HPS, such as oncostatin M (OSM) and Galectin-1/3 ( 132 , 133 ). However, since most of these results are based on experimental HPS models, whether identical mechanisms exist in humans remains to be determined.…”